RMTG expands Cellgenic commercial operations into Argentina

REGENERATIVE MEDICAL TECHNOLOGY GROUP INC

REGENERATIVE MEDICAL TECHNOLOGY GROUP INC

RMTG

0.00
  • Regenerative Medical Technology Group expanded Cellgenic’s Latin America operations by establishing a regulated commercial platform in Argentina.
  • Argentina positioned as a South America hub for biologics distribution through licensed physicians, supported by compliance, training, technical resources.
  • Build-out includes expanding the Argentina sales team, scaling distribution into neighboring markets, growing physician education with ISSCA.
  • Move supports a broader strategy spanning physician education, biologics commercialization, lab capabilities, international distribution across more than 30 countries.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regenerative Medical Technology Group Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202607230702ACCESSWRNAPR_____1195290) on July 23, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.